FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

FDA Approves Ionis/AstraZenecas Wainua

[ Price : $8.95]

FDA approves Ionis/AstraZenecas Wainua to treat adults with polyneuropathy of hereditary transthyretin-mediated amyloidosis.

Quality System Issues at Argentinas Terragene

[ Price : $8.95]

FDA warns Argentinas Terragene S.A. about Quality System violations in its manufacturing of Biological and Chemical Sterilization ...

Turkish Drug Company Has CGMP Issues: FDA

[ Price : $8.95]

FDA warns Avcilar/Istanbul, Turkey-based Sudesan Temizlik Urunleri Ve Ambalaj Sanaryi Ticaret Anomin Sirketi about CGMP violations...

Clinical Investigation Didnt Follow Plan: FDA

[ Price : $8.95]

FDA warns Anish Shah, doing business as Siyan Clinical Research in Santa Rosa, CA, about not following the investigational plan fo...

Update on FDA Real-World Evidence Activities

[ Price : $8.95]

FDA commissioner Robert Califf says the agency recently published three additional guidances to help advance the use of real-world...

Real-World Data Registries Guidance

[ Price : $8.95]

FDA publishes a guidance on assessing registries to support drug and biologic regulatory decision-making as part of its real-world...

ResMed Updates Labeling for Masks with Magnets

[ Price : $8.95]

FDA says ResMed has issued updated instructions for its masks with magnets to inform users about potential magnetic interference w...

Rare Disease Drug Development Guidance

[ Price : $8.95]

FDA publishes a guidance to assist sponsors in conducting efficient and successful drug development programs to treat rare disease...

Drug Development Master Protocol Guidance

[ Price : $8.95]

FDA publishes a draft guidance making recommendations on the design and analysis of drug development trials conducted under a mast...

Updated Labeling for Promethazine HCl

[ Price : $8.95]

FDA requires updated labeling for promethazine HCl injection to recommend administration through deep intramuscular rather than in...